These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3495753)

  • 1. [Use of miocamycin in the acute exacerbation of chronic obstructive bronchopneumopathy. Case material contribution].
    Miravalle C; Ardizzi A; Barberis S; Galietti F; Giorgis GE; Oliaro A
    Minerva Med; 1987 May; 78(9):623-6. PubMed ID: 3495753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinico-functional observations on the use of guacetisal in the treatment of chronic obstructive bronchopneumopathy].
    Lappa B; Di Caterina N; Perna A; Di Fraia C; Verdoliva A; Margarita A
    Minerva Med; 1981 Feb; 72(7):387-92. PubMed ID: 7017489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miocamycin doesn't affect theophylline serum levels in COPD patients.
    Dal Negro R; Turco P; Pomari C; de Conti F
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):27-9. PubMed ID: 3261281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trials of a new preparation in chronic bronchopneumopathies].
    Zuccali G; Gherson G; Parenti M
    Minerva Med; 1981 Feb; 72(7):451-8. PubMed ID: 7017497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of a preparation with bronchomucotropic activity: guacetisal].
    Rubegni M; De Mauro G
    Minerva Med; 1981 Feb; 72(7):429-33. PubMed ID: 7017495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guacetisal in the treatment of acute and chronic bronchopneumopathy].
    Carpinteri F; Carosi M
    Minerva Med; 1981 Feb; 72(7):347-53. PubMed ID: 7017484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience in treating patients with chronic obstructive bronchitis with fenspirid].
    Kirichenko AA; Shabanova TM
    Ter Arkh; 2002; 74(8):52-5. PubMed ID: 12360597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in a double-blind crossover experiment on chronic obstructive bronchopneumopathy].
    Iaia E
    Boll Chim Farm; 1990; 129(10-11):60S-67S. PubMed ID: 2102704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of guaiacolic ester of acetylsalicylic acid on spirometric and plethysmographic parameters in subjects with chronic obstructive bronchopneumopathy].
    Bonaduce D; Postiglione M; Ferrara N; Petretta M; De Caprio L; Rengo F
    Minerva Med; 1981 Feb; 72(7):333-7. PubMed ID: 7017482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of a new drug, guacetisal, in the treatment of acute and chronic bronchopneumopathy].
    Guerrini M; Carosi M
    Minerva Med; 1981 Feb; 72(7):371-8. PubMed ID: 7017487
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with miocamycin in the treatment of respiratory tract infections.
    Rimoldi R; Fioretti M; Bandera M
    Drugs Exp Clin Res; 1985; 11(4):263-8. PubMed ID: 3879725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of bronchopulmonary cancer in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Morgenstern H; Burnea D; Cristea M; Mangiulea V; Prutcanu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(3):211-8. PubMed ID: 6296976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and tissue distribution of miocamycin].
    Fraschini F; Scaglione F; Cantarella G; Marchi E; Scarpazza P
    Ann Ist Super Sanita; 1987; 23(4):887-90. PubMed ID: 3502552
    [No Abstract]   [Full Text] [Related]  

  • 14. [Miocamycin in the prevention and treatment of cutaneous infections in the emergency service].
    Bertinieri G; Caser L; Ceffa G; Cortese P; Martina C; Riccardi G; Calogero G
    Minerva Med; 1987 Nov; 78(21):1625-7. PubMed ID: 3500430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity.
    Agostoni C; Giovannini M; Fraschini F; Scaglione F; Galluzzo C; Riva E; Ferrara F
    J Int Med Res; 1988; 16(4):305-11. PubMed ID: 3262546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of the clinical course and treatment of chronic obstructive lung diseases against a background of lymphoproliferative diseases].
    Provotorov VM; Kazabtsov AIu
    Ter Arkh; 1997; 69(3):19-23. PubMed ID: 9229820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy using 9,3"-di-O-acetyl-midecamycin with beta-lactam antibiotics against Pseudomonas aeruginosa infection.
    Mashimo K; Homma JY; Iki Y; Inatomi K; Kasai T; Kunii O; Shimada K; Tanimoto H; Takigami T; Nishimura Y
    Jpn J Exp Med; 1981 Oct; 51(5):271-85. PubMed ID: 6798249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Miocamycin in ambulatory dental surgical practice].
    Capuzzi P; Mazzanti F; Balla G; Tani P
    G Stomatol Ortognatodonzia; 1986; 5(3):49-51. PubMed ID: 3499403
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with miocamycin in bacterial diseases of odontostomatological relevance].
    de Rysky S; Menghini P; Pozzoli PA
    Minerva Stomatol; 1985; 34(5):871-80. PubMed ID: 3878934
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of chronic obstructive bronchitis. Respiratory function tests before and after treatment with Bronchicum elixir].
    Nolte D
    Fortschr Med; 1971 Aug; 89(22):891-3. PubMed ID: 5154178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.